Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - pablo+engel
1
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Recombinant fusion proteins and complement inhibitors targeting P-selectin, and therapeutic and diagnostic application
Technology: Inventors at MUSC have designed fusion proteins to treat inflammatory and other related pathologies by binding p-selectin (PSel) and modulating complement. Although targeting complement has shown great promise in treating numerous pathologies which has also led to the approval of multiple drugs (e.g. eculizumab, Berinert, Cinryze), targeting...
Published: 7/22/2023
|
Inventor(s):
Stephen Tomlinson
,
Ali Alawieh
,
Pablo Engel
Keywords(s):
Category(s):
BioPharma